Citations
OncoPolyPharmacology Stripe Plot
Options
Drug A
Drug B
 
Highlight
0 Cells Selected
Breast
EFM192B
KPL1
MDAMB436
OCUBM
T47D
ZR751
Colon
COLO320DM
DLD1
HCT116
HT29
LOVO
RKO
SW620
SW837
Lung
A427
MSTO
NCIH1650
NCIH2122
NCIH23
NCIH460
NCIH520
SKMES1
Melanoma
A2058
A375
HT144
RPMI7951
SKMEL30
UACC62
Ovarian
A2780
CAOV3
ES2
OV90
OVCAR3
PA1
SKOV3
UWB1289
UWB1289BRCA1
Prostate
LNCAP
VCAP
0 Drugs Selected
Experimental
ABT-888
AZD1775
BEZ-235
Bortezomib
Dasatinib
Dinaciclib
Erlotinib
geldanamycin
L778123
Lapatinib
MK-2206
MK-4541
MK-4827
MK-5108
MK-8669
MK-8776
MRK-003
PD325901
Sorafenib
Sunitinib
Temozolomide
Zolinza
Approved
5-FU
Carboplatin
Cyclophosphamide
Dexamethasone
Doxorubicin
Etoposide
Gemcitabine
Metformin
Methotrexate
Mitomycine
Oxaliplatin
Paclitaxel
SN-38
Topotecan
Vinblastine
Vinorelbine

O'Neil, J., Benita, Y., Feldman, I., et al. "An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies." Molecular Cancer Therapeutics, 2016. 15(6): p. 1155-62.

Twarog, N.R., Stewart, E., Hammill, C.V., & Shelat, A.A. "BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action." Scientific Reports, 2016, 6 p. 25523.